• 90 Hits
  • Search Condition : Filter (MeSH = Antineoplastic Agents / therapeutic use*)
Species Resource Title
Human and Animal Cells Jurkat(RCB0806) Apoptotic Effects of a Thioether Analog of Vitamin K3 in a Human Leukemia Cell Line.
Human and Animal Cells Meth-A(RCB0464) Requirement of the acquired immune system in successful cancer chemotherapy with cis-diamminedichloroplatinum (II) in a syngeneic mouse tumor transplantation model.
Human and Animal Cells HKBMM(RCB0680) Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma.
Human and Animal Cells MMAc·SF(RCB1200) Phenotype-based probabilistic analysis of heterogeneous responses to cancer drugs and their combination efficacy.
Human and Animal Cells LM8(RCB1450) Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma.
Human and Animal Cells HS-Sch-2(RCB2230) Appropriate modulation of autophagy sensitizes malignant peripheral nerve sheath tumor cells to treatment with imatinib mesylate.
Human and Animal Cells Lu-165(RCB1184) SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.
Human and Animal Cells LNCap.FGC(RCB2144) KCa1.1 K+ Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid Model.
Human and Animal Cells HeLa , A549 , MCF7(RCB1904) , MKN74(RCB1002) , A431 , PANC-1(RCB2095) , MIA Paca2(RCB2094) , 1B2C6(RCB0795) , 1C3D3(RCB0796) Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth.
Human and Animal Cells HTC/C3(RCB0452) Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells.
Human and Animal Cells J774.1(RCB0434) Anti-protein-bound polysaccharide-K monoclonal antibody binds the active structure and neutralizes direct antitumor action of the compound.
Human and Animal Cells 293T(RCB2202) , KLM-1(RCB2138) , T3M-4(RCB1021) , PK-8(RCB2700) , PK-59(RCB1901) SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2.
Human and Animal Cells Ba/F3(RCB0805) Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation.
Human and Animal Cells SAS(RCB1974) Novel acridine-based N-acyl-homoserine lactone analogs induce endoreduplication in the human oral squamous carcinoma cell line SAS.
Human and Animal Cells Lu99(RCB1900) Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers.
Human and Animal Cells LU99(RCB1900) , LU65(RCB1967) , IA-LM(RCB0554) The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.
Human and Animal Cells J#176-3.2(RCB1918) Novel knock-in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin-targeting agents.
Human and Animal Cells HuH-7(RCB1366) Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin.
Human and Animal Cells MKN45(RCB1001) Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase.
Human and Animal Cells HuH-7 mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.